Brazilian COVID-19 data study completed: what 361,000 hospitalizations reveal
NCT ID NCT06652451
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed study looked back at data from over 361,000 people hospitalized with COVID-19 in Brazil. Researchers used a public health database to describe patient characteristics and outcomes, such as death rates. They also compared the impact of vaccination on immunocompromised patients versus the general population. The goal was to better understand how COVID-19 affected the Brazilian healthcare system.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
São Paulo, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What happens to the immune system after COVID-19? a major study aims to find out.
- Hidden toll of routine ICU procedure revealed: suctioning may spike pain and stress
- COVID-19's skin secrets: could chilblains hold clues to the virus?
- Scientists create COVID-19 biobank to unlock disease secrets
- What happens to severe COVID-19 survivors after the ICU?
- Experimental cell treatment shows promise for COVID-19 lung failure